Top Banner
EphMRA CONFERENCE MASTERCLASS Social Media & Market Research
70

Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Aug 20, 2015

Download

Business

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

EphMRA CONFERENCE MASTERCLASS Social Media & Market Research

Page 2: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Main Title

slide wording

goes here

EphMRA CONFERENCE MASTERCLASS Conversation Research: Leveraging the

power of Social Media in pharmaceutical Market Research

Page 3: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

I’m Robert

I am 45 years, working in London,

living with the 3 boys &

2 women of my life. Experienced

researcher, passionate

Marketer (fellow at Chartered

Institute for Marketing & Chartered

Marketer), Managing Director UK

InSites, Health Marketing expert

and committed to help companies

in their quest to connect better

with their patients and HCPs.

Page 4: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research
Page 5: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

What this Masterclass will cover

How the development of social media use in healthcare research is changing

Usage of different types of social media tools to meet your research goal

Explore pros and cons of each types

Case studies to demonstrate various methods and their applications Janssen Diabetes – combination of open and closed

listening/observing Merck Sereno – Engaging patients & HCPs in cardiovascular care

Page 6: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Changes in Social Media

Companies need to find new ways to be relevant and stay ahead of the pack.

using new technologies with lower costs despite global warming of

research panels … and – being marketers – we

also want to support our patients get to live forever using our medication

are fast & furious

Page 7: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Creative Destruction

Page 8: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

#Fact

We are sitting on a pile of

research information

Page 9: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

#Fact

We keep on

collecting new data

Page 10: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

If we only knew

what we already know…

Page 11: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Subheading texts…

Subheading texts…

Lorem ipsum dolor sit amet,

consectetuer adipiscing elit, sed diam

nonummy nibh euismod tincidunt ut

laoree. Ut wisi enim ad minim veniam,

quis nostrud exerci tation ullamcorper

suscipit lobortis nisl.

Duis autem vel eum iriure dolor in

hendrerit in vulputate velit esse

molestie consequat, vel illum dolore eu

feugiat nulla facilisis at vero eros et

accumsan et iusto odio dignissim qui

blandit praesent luptatum zzril delenit

augue duis dolore te feugait nulla.

It’s hard

Page 12: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

beyond the obvious

It’s hard…

Leve

ra

ge

YE

S

NO

Known Unknown

I don’t know

where to

start

I don’t know

what I don’t

know

Page 13: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

“The patient is to be

at the heart of all our innovation,

branding and communication.”

“Recognize this mission?

It’s hard…

Page 14: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

beyond intuition and trends

It’s hard…

Page 16: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

to imagine the future

It’s hard…

Page 17: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

So, Where to

Start?

Page 18: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research
Page 19: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Patients have stepped forward

to actively participate in the

conversations about their health

Page 20: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

1 2 3

Page 21: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

e-Patient Dave

“Gimme my damn data”

Diagnosed with stage IV kidney cancer 2007

Took an active role in his treatment & survived

Inspiration for Novartis

Current job: healthcare consultant!

@ePatientDave

Page 22: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Patients 1st power tool is information

The internet enables them to look for

information themselves.

Dr. Google is their guide in their search.

that is out there

Page 23: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

72%

Users

87%

82%

74%

97%

95%

79%

79%

80%

83% already used the internet to look for information on health related topics

Source: Health study by InSites Consulting 2010

70%

69%

Page 24: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

engaged patient

=

emotional patient

Sharing = caring

When patients share information, it is not limited to

exchanging rational information (treatments,

products, symptoms…)

They all feel the urge to share emotions,

concerns, issues… It is very reassuring to read

stories in which they recognize themselves

Page 25: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

of patients says info found online affects decision about treatments

56% says it changed their overall

approach to maintaining their health

or the health of someone they help

take care of.

53% says it leads to ask a doctor a

new question or to get a second

opinion from another doctor.

Online information is impactful.

Source: http://www.slideshare.net/PewInternet/2012-1-12-12-rise-of-epatients-providence-st-joseph-medical-centerpptx

60%

Page 26: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Patients have changed So need you: You need to observe what they are doing You need to engage With the right patient!

Page 27: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

The world as it used to be

Page 28: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Research has changed from asking questions to having a conversation

Engagement Market Research Online Communities Multimedia Ethnography

Nethnography Social Media Dashboard – monitoring Social Media Audit Social Media Listening/Nethography

Page 29: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Research has changed from asking questions to having a conversation

Nethnography Social Media Dashboard – monitoring Social Media Audit Social Media Listening/Nethography

Page 30: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

ANALYSIS

SURVEY/ TOPIC GUIDE DEVELOPMENT

SAMPLING

RESPONDENTS

FRAMEWORK

DEVELOPMENT

SAMPLING

UNIVERSE DETECTION

PASSIVE

DATA COLLECTION

Traditional research Social media nethnography

TOP-DOWN &

BOTTOM-UP

CONTENT & TEXT

ANALYTICS

ACTIVE

DATA COLLECTION

Reversed research process

Page 31: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

31

Universe detection

Page 32: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Representativeness

„It‟s the end of the world as we know it‟

32

Page 33: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Conversations are the new unit of analysis

Page 34: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Sampling is still key

34

Page 35: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Vis

ito

rs

# sources

Small #

Large influence

Medium influence

Specialized in topics Long tail

Page 36: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Data collection

Page 37: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Historical data

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

week 1

week 2

week 3

week 4

week 5

week 6

week 7

week 8

week 9

week 10

week 11

week 12

brand 1 65% 82% 64% 63% 50% 25% 23% 35% 40% 45% 48% 49%

Market 75% 55% 55% 48% 29% 54% 58% 60% 65% 63% 68% 70%

Page 38: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Public & fan pages only

Play by the rules! (note: AE

reporting)

Page 39: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

3.Qualitative analysis

2.Associative pattern

recognition

1. Descriptive taxonomy detection

To what extent do we find our research

topics back?

Which terms often co - occur? Which

concept are often mentioned bottom - up?

Analyse original verbatims via qualitative

content analysis

Observational

research

Analysis process

Page 40: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Emoti

ons

Excitement

Relaxed

Social

Beauty

Violence

Swear words

Despair

Weak

Loneliness

Elated, Excited, Enthusiastic

Contented, Relaxed, Satisfied

Happiness

Happy Joyful

Cheerful Satisfied

Proud Trust, Love, Respect

Beautiful, Admired, Attractive

Aggressive, Abusive, Dominating

Agony, Despair, Ashamed

Tired , Bored, Weak

Lonely, Rejected, Alienated

Surprise

Amazed Surprised

Astonished

Fear

Afraid Nervous

Tense Worried

Insecure

Anger

Angry Furious

Mad Irritated

Resentful

Sadness

Sad Disappointed

Regretful Gloomy

Pessimistic

Disgust

Disgust Contempt

Nasty

Page 41: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

What is the share of voice for the

different treatments for epilepsy?

0,00%

1,00%

2,00%

3,00%

4,00%

5,00%

6,00%

7,00%

8,00%

9,00%

10,00%

June July August September October November

Keppra 5,74% 4,73% 5,81% 4,92% 4,49% 3,45%

Lamictal 4,90% 4,33% 5,02% 3,91% 3,54% 3,40%

Topamax 2,23% 1,58% 1,29% 1,45% 0,86% 1,57%

Depakote 0,95% 1,10% 1,47% 1,76% 1,72% 0,83%

Trileptal 1,96% 1,47% 1,41% 1,45% 0,77% 0,61%

Vimpat 1,61% 1,72% 1,01% 0,86% 0,41% 0,31%

The number of conversations about

Keppra and Vimpat decreased over the

last half year.

Page 42: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

0

-20

10

-10

-40

-30

20

30

40

50

60

70

80

90

-50

Sentimeter - Brands for treatment of Epilepsy (top 10

brands with most buzz)

N = 281

Vimpat

0,38

0

-20

10

-10

-40

-30

20

30

40

50

60

70

80

90

-50

N = 156

Epilim

0,33

0

-20

10

-10

-40

-30

20

30

40

50

60

70

80

90

-50

N = 221

Trileptal

0,28

0

-20

10

-10

-40

-30

20

30

40

50

60

70

80

90

-50

N = 1037

Lamictal

0,25

0

-20

10

-10

-40

-30

20

30

40

50

60

70

80

90

-50

N = 341

Topamax

0,25

0

-20

10

-10

-40

-30

20

30

40

50

60

70

80

90

-50

N = 138

Lamotrigine

0,23

0

-20

10

-10

-40

-30

20

30

40

50

60

70

80

90

-50

N = 306

0,41

0

-20

10

-10

-40

-30

20

30

40

50

60

70

80

90

-50

N = 1341

Keppra

0,21

0

-20

10

-10

-40

-30

20

30

40

50

60

70

80

90

-50

N = 129

Diastat

0,19

0

-20

10

-10

-40

-30

20

30

40

50

60

70

80

90

-50

N = 192

Dilantin

0,14

Sentiment about Depakote is significantly more positive in comparison with other brands.

Comparing the current results with the results of last year (different calculation method),

we observe that sentiment on Keppra decreased relatively compared to other brands.

Page 43: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

In Summary

………………………………………………………………………………………………….…….

………………………………………………………………………………………………….…….

Page 44: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Social media netnography: benefits

Access to highly involved patient and difficult topics Many conversations Most on relevant topics Ideal to explore new TAs/topics

Page 45: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Social media netnography: limitations

Less of the uninvolved patient No probing Only what is relevant for them Internet has no boundaries

Page 47: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Research has changed from asking questions to having a conversation

Engagement Market Research Online Communities Multimedia Ethnography

Page 48: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Follow a selection of patients. Step

into the patient’s shoes. Experience

their condition as they do.

Process • Patients receive a camera • Online, through a blog, created

for the purpose of the study, and commenting tools

• During a longer period of time (> 1 week)

Output • Insights embedded in real-life

situations • Visualized context (photos,

movies...) • Emotionally enriched evidence

Patient led Ethnography

Page 50: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Diabetes has a severe impact on the overall energy level of patients. However, some of them try to blame their loss of energy on getting older. Patients try to find solutions for their energy loss: -They take on less activities -Work less hours -They find calmer hobbies

In the shoes of the Diabetic patient I am forever

getting tired, or

having to go to

bed for a nap

Tropical fish is

a relaxing

diversion

I work at home

to avoid stress

and to rest

Page 51: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Get insights into hypertension

CASE:

Heart to Heart Talk

Merck Serono

OBJECTIVE:

Understand the patients’ lifestyle.

Get insights in the role of hypertension in their lives.

Translate new insights into relevant patient services.

Page 52: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

SAY ‘Hi’ TO

YOUR

PATIENT

CONSULTING

BOARD

Page 53: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research
Page 54: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

The patient consulting board

1

2

3

Blog

Crowd

Interpretation

Discussions

1 2 3

Page 55: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

1. Online ethnography

OBSERVING hypertension patients by asking them to blog about their life

Page 56: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Get immersed

in the life of patients

Explore typical

hypertension moments

Discover routines

hypertension moments

Page 57: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

2. Crowd interpretation game

Interpret and explain the patient stories to generate more and new insights

Page 58: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Observation

Meaningful

observation

Interpretation

insight

Let the magic begin

Page 59: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Crow

d

inte

rpreta

tion

Page 60: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

360° interpretation

55 patients

With hypertension

24 HCP’s

50 peers

Page 62: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

The outsiders perspective

360° patient support

Societal influence

Holistic

Innovative

Empowered patient

Talking versus doing

Page 63: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Peers versus HCP’s

Peers HCP

Challenging medical

advice

Compliance work

arounds

New medication

Page 64: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

3. Discussion stage

Further shape insights and explore useful services to hypertension patients

Page 65: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

In Summary

………………………………………………………………………………………………….…….

………………………………………………………………………………………………….…….

Page 66: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

72

Online Communities & Ethnography: PRO

Be part of daily life & context Looking through their eyes Longer time span allows for richer feedback Sample can be controlled and probing is possible

Page 67: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Online Communities & Ethnography: CON

Patients hide idiosynracies Only online patients More difficult to find involved patients

Page 69: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

New York I Timisoara I London I Rotterdam I Ghent

@Robert_Dossin

http://uk.linkedin.com/in/robertdossin

+44 7904 288 898

[email protected]

Page 70: Conversation Research: Leveraging the power of Social Media in pharmaceutical market research

Founded 1997 as a business school spin-off

Structure Fully independent, 7 managing partners

Growth Average yearly growth +25%

Locations USA I ROM I UK I NL I BE

Team 125 passionate & talented people

Reach Global Consumer & Moderator Network

Clients +35% of 2012 Best Global Brands (Interbrand)

Awards ESOMAR I AMA I ARF I MRS I MOA I AMMA